Danaher acquires German quality inspection firm Laetus for undisclosed price

Danaher ($DHR), a U.S.-based health technology company, has acquired Laetus, a Germany-based maker of inline quality inspection and track-and-trace systems, for an undisclosed amount. The deal is expected to bolster Laetus' position in R&D as well as grow its global presence based on Danaher's reputation, the company said in a release. Alex Lever, managing director at Laetus, said the combination will grow what the company has to offer to the packaging value chain. "This acquisition reaffirms the Laetus strategy and accomplishments to date," said Christoph Staub, a Laetus general manager. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.